fda bans glp 1 compounding Did the Ban Compounded Semaglutide and Tirzepatide? Bait and Switch -The FDA

GLP-1 medications alter intestinal motility and secretion, causing diarrhea in some users

60 Billion CFU Probiotics FormulaHigh-efficiency probiotics and prebiotics support a balanced gut microbiota and digestive comfort

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

This includes large countries such as India, Canada, China, Brazil and Turkey which make up 40% of the worlds population and an estimated 33% of the worlds population of adults living with obesityi (see Figure 1)

The association is specific to NAION